MTE Sessions

(Please note this programme is subject to change)

Change your timezone preference

Day 1- Friday, 10 April

11:10 AM - 11:50 AM (BST)
Meet the Experts
Earlier is Better: The Benefits of Timely Diagnosis and Intervention in CKM Syndrome

  • Cardiovascular-kidney-metabolic Syndrome: The Critical Importance of Early Diagnosis – Carol Pollock

  • Screening for Heart Failure in Patient with Diabetes: Insights from TARTAN-HF – Mark Petrie

 



Supported by unrestricted educational grant funding from AstraZeneca


2:10 PM - 2:50 PM (BST)
Meet the Experts
Implementation of Evidence-based Therapies for CKM Conditions: How to Move Forward?

  • Implementation of Evidence-based Therapies for Cardiovascular Kidney-metabolic Conditions – Are we on Track? – Stephen Greene

  • Translating Knowledge into Practice – How can Implementation Science Help? – Christoph Wanner

 



Supported by unrestricted educational grant funding from AstraZeneca


4:10 PM - 4:50 PM (BST)
Meet the Experts
A New Weapon for an Old Target: Aldosterone Synthase Inhibition in Cardiovascular & Kidney Disease

  • Targeting Aldosterone in Cardiovasular and Kidney Disease: The Therapeutic Potential of Aldosterone Synthase Inhibitors – David Cherney

  • Benefits of Aldosterone Synthase Inhibitors in Patients with Cardiorenal Disease: Current Clinical Evidence – Javed Butler

 



Supported by an unrestricted educational grant from Boehringer Ingelheim


7:10 PM - 7:50 PM (BST)
Meet the Experts
Targeting Mineralocorticoid Receptor Overactivation Across the CKM Continuum: From Landmark Trials to Integrated Clinical Practice

  • From Trial Evidence to Clinical Decision: What the Finerenone Programme Means for your CKD Patients – Amy Mottl

  • The Polytherapy Challenge: How to Sequence and Combine Finerenone in Real-World CKM Practice – Muthiah Vaduganathan



Supported by an unrestricted educational grant from Bayer


9:10 PM - 9:50 PM (BST)
Meet the Experts
Replay of 'Earlier is Better: The Benefits of Timely Diagnosis and Intervention in CKM Syndrome'

Supported by unrestricted educational grant funding from AstraZeneca



Register for free

Day 2 - Saturday, 11 April

11:10 AM - 11:50 AM (BST)
Meet the Experts
Replay of 'Targeting Mineralocorticoid Receptor Overactivation Across the CKM Continuum: From Landmark Trials to Integrated Clinical Practice'

Supported by an unrestricted educational grant from Bayer


2:10 PM - 2:50 PM (BST)
Meet the Experts
Replay of 'A New Weapon for an Old Target: Aldosterone Synthase Inhibition in Cardiovascular & Kidney Disease'

Supported by an unrestricted educational grant from Boehringer Ingelheim


4:10 PM - 4:50 PM (BST)
Meet the Experts
Don’t Overlook the Liver! Advances in the Management of Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Don't Overlook the Liver! MASH and the Cardiovascular-kidney-liver-metabolic Syndrome – Sven Francque

  • Current and Emerging Treatments for MASH and Associated Conditions – Antonio Ceriello



Supported by an unrestricted educational grant from Boehringer Ingelheim



Register for free

Sponsors

If you’re interested in becoming an educational partner or sponsor at this event, please contact [email protected]

About KDIGO

KDIGO is a global organisation developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed foundation incorporated in Belgium and accountable to the public and the patients it serves.

KDIGO’s mission is to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines.

For more information on KDIGO, please visit https://kdigo.org.

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science

  • We work hands-on with our community

  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com

Please contact [email protected] should you have any queries.